Search results for " LAMA"

showing 10 items of 19 documents

Saproksilo bezmugurkaulnieku daudzveidība lapkoku praulgrauža Osmoderma barnabita (Coleoptera, Scarabaeidae) dzīvotnēs Rundāles novadā

2018

Lapkoku praulgrauzis īpaši aizsargājama suga un indikators lielai saproksilo bezmugurkaulnieku daudzveidībai, saproksilie bezmugurkaulnieki ir paaugstinātā riska grupā saistībā ar to biotopu skaita samazināšanos. Rundāles novadā ir vairākas teritorijas, kuras ir piemērotas lapkoku praulgrauzim kā dzīvotnes. Nav zināms kopējais lapkoku praulgrauža dzīvotņu skaits Rundāles novadā un nav informācijas par to saproksiliem bezmugurkaulniekiem tajās. Izmantojot feromonu lamatas, lai noteiktu lapkoku praulgrauža klātbūtni biotopa līmenī, un parbaudi uz ekskrementiem kokos, lai noteiktu apdzīvotos dobumainos kokus. Izmantojot sijāšanas metodi, ievākt dobumaino koku praulu paraugus un tad laboratorij…

pārbaude uz ekskrementiemLapkoku praulgrauzissijāšanaBioloģijaSaproksilie bezmugurkaulniekiferomonu lamatas
researchProduct

Saproksilo plēvspārņu daudzveidību ietekmējošie faktori mežu degumos Latvijā

2019

Šajā darbā, “Īpaši aizsargājamo kukaiņu sugu un to dzīvotņu inventarizācija biotopu direktīvā iekļauto sugu un Biotopu aizsardzības stāvokļa izvērtējuma kontekstā” projekta ietvaros, atsevišķi tuvāk tika pētīti vecos un dabiskos boreālos mežos mītoši saproksilie plēvspārņi un to daudzveidību ietekmējošie faktori. Plēvspārņi ar logu lamatu metodi tika ievākti 5 Latvijas ainavzemēs. Kopumā ievākti 1391 kukaiņi no 14 plēvspārņu kārtas dzimtām un izvērtējot morfoloģiskās atšķirības (izņemot jātnieciņu dzimtas kukaiņus), atšķirtas 88 morfosugas. Izvērtējot mainīgos faktorus un kukaiņu dauzdveidību secināts, ka degumos plēvspārņu ir būtiski vairāk kā nedegušos mežos. Lielāka deguma platība, degum…

Dabiski boreāli mežiDegumiSaproksilie plēvspārņiBioloģijaDaudzveidībaLoga lamatas
researchProduct

Day and Night Control of COPD and Role of Pharmacotherapy: A Review

2020

Abstract The topic of 24-hour management of COPD is related to day-to-night symptoms management, specific follow-up and patients’ adherence to therapy. COPD symptoms strongly vary during day and night, being worse in the night and early morning. This variability is not always adequately considered in the trials. Night-time symptoms are predictive of higher mortality and more frequent exacerbations; therefore, they should be a target of therapy. During night-time, in COPD patients the supine position is responsible for a different thoracic physiology; moreover, during some sleep phases the vagal stimulation determines increased bronchial secretions, increased blood flow in the bronchial circ…

nightLABAReviewMuscarinic AntagonistsSettore MED/10 - Malattie Dell'Apparato Respiratoriocopd – symptoms – dyspnea – night – sleep – follow-up – adherence – circadian lama – laba – icsAdherence; Circadian; COPD; Dyspnea; Follow-up; Night; Sleep; SymptomsPulmonary Disease Chronic ObstructiveAdrenal Cortex HormonesAdministration InhalationSettore MED/10follow-upCOPDHumansadherencesleepAdrenergic beta-2 Receptor Agonistslcsh:RC705-779Circadianlcsh:Diseases of the respiratory systemdyspnearespiratory tract diseasesBronchodilator Agentscircadian LAMAICSsymptomsAdherence Circadian COPD Dyspnea Follow-up Night Sleep SymptomsInternational Journal of COPD
researchProduct

Tekstiili- ja vaatetusalan perheyritysten selviäminen 1990-luvun lamasta

1998

tekstiili- ja vaatetusalaSuomen 1990-luvun lamaperheyritykset
researchProduct

Effects of aclidinium on determinants of COPD severity: symptoms and quality of life

2016

Marco Contoli,1 Paolo Solidoro,2 Fabiano Di Marco,3,4 Nicola Scichilone,5 Angelo Corsico,6 Fulvio Braido,7 Pierachille Santus4,8 1Research Centre on Asthma and COPD, Department of Medical Sciences, University of Ferrara, Ferrara, Italy; 2Cardiovascular and Thoracic Department, Città della Salute, Turin, Italy; 3Department of Health Sciences, University of Milan, Milan, Italy; 4Respiratory Unit, San Paolo Hospital, Milan, Italy; 5Department of Internal Medicine, Section of Pulmonology (DIBIMIS), University of Palermo, Palermo, Italy; 6Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; 7Allergy and Respiratory Diseases Clinic, DIMI, University of G…

Time FactorsReviewdaily symptomsAclidinium; COPD; Daily symptoms; LAMA; Quality of life; Pulmonary and Respiratory Medicine; Health Policy; Public Health Environmental and Occupational HealthSeverity of Illness IndexPulmonary Disease Chronic Obstructive0302 clinical medicineBronchodilatorMedicine030212 general & internal medicineLungCOPDHealth PolicyTropaneLAMAGeneral MedicineBronchodilator AgentsMuscarinic AntagonistTreatment OutcomeTolerabilityChronic inflammatory responsePublic HealthHumanPulmonary and Respiratory MedicineChronic Obstructivemedicine.medical_specialtyTime Factormedicine.drug_classBronchoconstrictionSocio-culturaleMuscarinic AntagonistsSettore MED/10 - Malattie Dell'Apparato RespiratorioPulmonary Disease03 medical and health sciencesAclidinium bromideaclidiniumAclidinium; COPD; Daily symptoms; LAMA; Quality of life; Bronchoconstriction; Bronchodilator Agents; Humans; Lung; Muscarinic Antagonists; Pulmonary Disease Chronic Obstructive; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome; Tropanes; Quality of LifeInternal medicineSeverity of illnessAnticholinergicCOPDHumansAdverse effectBronchodilator Agentlcsh:RC705-779business.industryEnvironmental and Occupational HealthDaily symptomPublic Health Environmental and Occupational Healthlcsh:Diseases of the respiratory systemRecovery of Functionmedicine.diseasequality of life030228 respiratory systemPhysical therapybusinessTropanesInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Indacaterol/glycopyrronium/mometasone fixed dose combination for uncontrolled asthma

2021

INTRODUCTION Asthma symptoms can be relieved through a maintenance treatment combining long-acting β2-agonist and inhaled corticosteroids (LABA/ICS). However, for patients with inadequately controlled asthma, the LABA/ICS combination might not be sufficient. Under these conditions, clinical guidelines recommend the administration of inhaled long-acting muscarinic antagonists (LAMA) as an add-on therapy to LABA/ICS to better control asthma and improve lung function. For nearly two decades, the only LAMA to be approved on the market has been tiotropium. AREAS COVERED We reviewed recent clinical studies evaluating the safety and efficacy of LABA/LAMA/ICS fixed dose combinations by searching Pu…

Pulmonary and Respiratory Medicinemedicine.medical_specialtycorticosteroidFixed-dose combinationLABAAsthma corticosteroid fixed dose combination ICS inhaler LABA LAMA once daily combination uncontrolled asthmaMuscarinic Antagonistsonce daily combinationQuinolonesSettore MED/10 - Malattie Dell'Apparato RespiratorioinhalerAdrenal Cortex HormonesInternal medicineAdministration InhalationImmunology and AllergyMedicineHumansfixed dose combinationAdrenergic beta-2 Receptor AgonistsAsthmaFluticasonebiologyInhalationuncontrolled asthmabusiness.industryInhalerPublic Health Environmental and Occupational HealthLAMALamamedicine.diseasebiology.organism_classificationGlycopyrrolateFluticasone-Salmeterol Drug CombinationAsthmarespiratory tract diseasesDrug CombinationsICSIndansIndacaterolSalmeterolbusinessMometasone Furoatehormones hormone substitutes and hormone antagonistsmedicine.drug
researchProduct

Omakotihankkeen harkitsijat ja toteuttajat : mikä erottaa haaveen todellisuudesta?

1998

kodinomistusyhteiskuntaontologinen turvallisuusperhe1990-luvun lamaomakotiasumisen arvotasuntopolitiikkatyöyhteiskuntahallintaperusteriskitietoisuus
researchProduct

Effects of a structured educational intervention in moderate-to-severe elderly asthmatic subjects.

2019

Background: Adherence to inhaled drugs is linked to patients’ satisfaction with their device, and an incorrect use can negatively affect the outcomes of asthma treatment. We speculated that this is particularly true in elderly asthmatic subjects. Aim: We performed a national pre-post interventional multicentre study, enrolling moderate-to-severe asthmatic subjects aged ≥65 ​years treated with fixed inhaled combination drugs by dry powder inhaler (DPI) or pressurized metered dose inhaler (pMDI). Adherence and critical errors were evaluated by means of validated questionnaires at first visit (V1) and after 3–6 months (V2). At V1, subjects underwent intensive training on the correct use of the…

Vital capacityACT asthma control testExacerbationSAE severe asthma exacerbationSF12chlorofluorocarbonsmental health composite scoreEDUCA elderly and device use in chronic asthmaPCS physical health composite scoreACT asthma control test; AHDS hospital anxiety depression scale; Asthma; CFC chlorofluorocarbons; Device misuse; EDUCA elderly and device use in chronic asthma; Education; Elderly; FEV1 forced expiratory volume 1s second; FVC forced vital capacity; ICS inhaled corticosteroids; LABA long-acting β2 agonist; LAMA long-acting muscarinic antagonists; MCS mental health composite score; PCS physical health composite score; PROs patient-reported outcomes; SAE severe asthma exacerbation; SF12 short form health survey; mMRC modified medical research councilEDUCAFEV10302 clinical medicineElderlyImmunology and AllergyMedicine030223 otorhinolaryngologybiologymMRC modified medical research councilsevere asthma exacerbationmodified medical research councilLAMASAELamaelderly and device use in chronic asthmaMetered-dose inhalerDry-powder inhalerDevice misusePROs patient-reported outcomesCFCPCSpatient-reported outcomesmMRClcsh:Immunologic diseases. AllergyPulmonary and Respiratory Medicinelong-acting β2 agonistmedicine.medical_specialtyImmunologyLABAphysical health composite scoreArticleLAMA long-acting muscarinic antagonistsAHDSEducation03 medical and health sciencesFEV1/FVC ratiolong-acting muscarinic antagonistsforced vital capacitySF12 short form health surveyAsthma; Device misuse; Education; ElderlyInternal medicineMCS mental health composite scoreforced expiratory volume 1s secondAsthmabusiness.industryFEV1 forced expiratory volume 1s secondInhalerasthma control testbiology.organism_classificationmedicine.diseaseCFC chlorofluorocarbonsACTICS inhaled corticosteroidsFVCAsthmaMCShospital anxiety depression scale030228 respiratory systemICSAHDS hospital anxiety depression scaleFVC forced vital capacityPROsshort form health surveyinhaled corticosteroidslcsh:RC581-607businessLABA long-acting β2 agonistThe World Allergy Organization journal
researchProduct

Bišu (Hymenoptera: Anthophila) daudzveidība intensīvi un ekstensīvi apsaimniekotās lauksaimniecības teritorijās

2022

Savvaļas bites ir pasaulē nozīmīgi apputeksnētāji gan savvaļas veģetācijai, gan kultūraugiem. Eiropā un īpaši Latvijā bišu pētniecībā trūkst uzziņu par bišu sastopamību, izplatību un to spēju pielāgoties pieaugošai antropogēnajai ietekmei biotopos. Bišu daudzveidību dabā vienlaicīgi ietekmē daudzi ārēji faktori un to mijiedarbība ar bišu fenotipiem. Bakalaura darbā pētīta bišu daudzveidība divās dažādi apsaimniekotās lauksaimniecības teritorijās Saldus novadā 2021. gada vasarā. Paraugu ievākšanā tika izmantota ūdens lamatu metode. Bišu daudzveidība tika analizēta, izmantojot jauktu efektu modeļus. Uzskaitēs kopā ievākti 2175 indivīdi 96 dažādās bišu sugās. Bišu daudzveidība novērota būtiski…

bišu daudzveidībajaukto efektu modeļiBioloģijaūdens lamatassavvaļas bitesAnthophila
researchProduct

Du vol des oiseaux à l'évolution des espèces animales

2013

National audience; Étienne-Jules Marey se range du côté des partisans de l’évolution des espèces expliquée par le transformisme (1809) de Jean-Baptiste Lamarck (1744-1829). Marey déplore cependant que Lamarck demeure « beaucoup trop vague dans ses explications lorsqu’il attribue les changements des organismes vivants à des circonstances extérieures. Entre un besoin qui se révèle et l’apparition d’une forme organique qui corresponde à un besoin, il y a une lacune que sa théorie n’a pas comblée » . D’où chez Marey, des interrogations et le désir dans son champ de compétences de relever quelques faits avérés de transformations d’adaptation des êtres vivants à de nouvelles conditions de vie.

évolution des espècesJean-Baptiste Lamarck[SHS.INFO]Humanities and Social Sciences/Library and information sciencesEtienne-Jules Marey[ SHS.INFO ] Humanities and Social Sciences/Library and information sciences[SHS.INFO] Humanities and Social Sciences/Library and information sciences
researchProduct